Clinical practice. Irritable bowel syndrome.
Mayer
Emeran A
EA
Center for Neurobiology of Stress, Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-6949, USA. emayer@ucla.edu
D000328:Adult; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D002243:Carbolines / Q000627:therapeutic use; D015928:Cognitive Behavioral Therapy; D003891:Desipramine / Q000627:therapeutic use; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D007211:Indoles / Q000627:therapeutic use; D043183:Irritable Bowel Syndrome / Q000175:diagnosis / Q000209:etiology / Q000523:psychology / Q000628:therapy*; D008297:Male; D010276:Parasympatholytics / Q000627:therapeutic use; D017410:Practice Guidelines as Topic
D000929:Antidepressive Agents, Tricyclic; D002243:Carbolines; D005765:Gastrointestinal Agents; D007211:Indoles; D010276:Parasympatholytics; C090840:alosetron; C105050:tegaserod; D003891:Desipramine